237 related articles for article (PubMed ID: 22582077)
1. Lactobacillus reuteri protects epidermal keratinocytes from Staphylococcus aureus-induced cell death by competitive exclusion.
Prince T; McBain AJ; O'Neill CA
Appl Environ Microbiol; 2012 Aug; 78(15):5119-26. PubMed ID: 22582077
[TBL] [Abstract][Full Text] [Related]
2. Lactobacillus rhamnosus GG inhibits the toxic effects of Staphylococcus aureus on epidermal keratinocytes.
Mohammedsaeed W; McBain AJ; Cruickshank SM; O'Neill CA
Appl Environ Microbiol; 2014 Sep; 80(18):5773-81. PubMed ID: 25015889
[TBL] [Abstract][Full Text] [Related]
3.
Spacova I; O'Neill C; Lebeer S
Benef Microbes; 2020 Nov; 11(7):703-715. PubMed ID: 33084369
[TBL] [Abstract][Full Text] [Related]
4. A survey of multiple candidate probiotic bacteria reveals specificity in the ability to modify the effects of key wound pathogens.
Alhubail M; McBain AJ; O'Neill CA
Microbiol Spectr; 2024 May; ():e0034724. PubMed ID: 38700333
[TBL] [Abstract][Full Text] [Related]
5. Lactobacillus reuteri inhibits Staphylococcus aureus-induced mastitis by regulating oxytocin releasing and gut microbiota in mice.
He Z; Li W; Yuan W; He Y; Xu J; Yuan C; Zhao C; Zhang N; Fu Y; Hu X
FASEB J; 2024 Jan; 38(2):e23383. PubMed ID: 38197892
[TBL] [Abstract][Full Text] [Related]
6. Role of probiotics in the prevention and treatment of meticillin-resistant Staphylococcus aureus infections.
Sikorska H; Smoragiewicz W
Int J Antimicrob Agents; 2013 Dec; 42(6):475-81. PubMed ID: 24071026
[TBL] [Abstract][Full Text] [Related]
7.
Hu MX; He F; Guo YX; Mo LZ; Zhu X
J Agric Food Chem; 2022 Sep; 70(38):11935-11943. PubMed ID: 36111836
[TBL] [Abstract][Full Text] [Related]
8. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
Jansen PM; Abdelbary MMH; Conrads G
PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
[TBL] [Abstract][Full Text] [Related]
9. Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro.
Söderling EM; Marttinen AM; Haukioja AL
Curr Microbiol; 2011 Feb; 62(2):618-22. PubMed ID: 20835828
[TBL] [Abstract][Full Text] [Related]
10. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread.
Dommels YE; Kemperman RA; Zebregs YE; Draaisma RB; Jol A; Wolvers DA; Vaughan EE; Albers R
Appl Environ Microbiol; 2009 Oct; 75(19):6198-204. PubMed ID: 19684171
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus reuteri DSM 17938-A comparative study on the effect of probiotics and lysates on human skin.
Khmaladze I; Butler É; Fabre S; Gillbro JM
Exp Dermatol; 2019 Jul; 28(7):822-828. PubMed ID: 31021014
[TBL] [Abstract][Full Text] [Related]
12. Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines.
Ang LY; Too HK; Tan EL; Chow TK; Shek LP; Tham EH; Alonso S
Virol J; 2016 Jun; 13():111. PubMed ID: 27341804
[TBL] [Abstract][Full Text] [Related]
13. An in vitro investigation of the protective role of Staphylococcus Epidermidis extracts on Staphylococcus Aureus induced toxicity in human keratinocytes.
Mohammedsaeed W; Manzoor N
Indian J Med Microbiol; 2022; 40(2):239-244. PubMed ID: 35131138
[TBL] [Abstract][Full Text] [Related]
14. Antagonistic trait of Lactobacillus reuteri S5 against Salmonella enteritidis and assessment of its potential probiotic characteristics.
Shi S; Qi Z; Sheng T; Tu J; Shao Y; Qi K
Microb Pathog; 2019 Dec; 137():103773. PubMed ID: 31604155
[TBL] [Abstract][Full Text] [Related]
15. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci.
Li J; Wang W; Xu SX; Magarvey NA; McCormick JK
Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3360-5. PubMed ID: 21282650
[TBL] [Abstract][Full Text] [Related]
16. Glyceraldehyde-3-Phosphate Dehydrogenase Increases the Adhesion of
Deng Z; Dai T; Zhang W; Zhu J; Luo XM; Fu D; Liu J; Wang H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371288
[TBL] [Abstract][Full Text] [Related]
17. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
J Appl Microbiol; 2015 May; 118(5):1180-90. PubMed ID: 25688886
[TBL] [Abstract][Full Text] [Related]
18. Effect of Lactobacillus rhamnosus HN001 on carriage of Staphylococcus aureus: results of the impact of probiotics for reducing infections in veterans (IMPROVE) study.
Eggers S; Barker AK; Valentine S; Hess T; Duster M; Safdar N
BMC Infect Dis; 2018 Mar; 18(1):129. PubMed ID: 29540160
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Evaluation of Swine-Derived Lactobacillus reuteri: Probiotic Properties and Effects on Intestinal Porcine Epithelial Cells Challenged with Enterotoxigenic Escherichia coli K88.
Wang Z; Wang L; Chen Z; Ma X; Yang X; Zhang J; Jiang Z
J Microbiol Biotechnol; 2016 Jun; 26(6):1018-25. PubMed ID: 26907754
[TBL] [Abstract][Full Text] [Related]
20. Oral Vaccination with Engineered Probiotic Limosilactobacillus reuteri Has Protective Effects against Localized and Systemic Staphylococcus aureus Infection.
Pan N; Liu Y; Zhang H; Xu Y; Bao X; Sheng S; Liang Y; Liu B; Lyu Y; Li H; Ma F; Pan H; Wang X
Microbiol Spectr; 2023 Feb; 11(2):e0367322. PubMed ID: 36723073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
